Cargando…
Systemic immunotherapy of superficial mouse bladder cancer with Avelumab (MSB0010718C), an anti-PD-L1 immune checkpoint inhibitor
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645497/ http://dx.doi.org/10.1186/2051-1426-3-S2-P70 |
| _version_ | 1782400825971179520 |
|---|---|
| author | Vandeveer, Amanda Fallon, Jonathan Tighe, Robert Sabzevari, Helen Schlom, Jeffrey Greiner, John |
| author_facet | Vandeveer, Amanda Fallon, Jonathan Tighe, Robert Sabzevari, Helen Schlom, Jeffrey Greiner, John |
| author_sort | Vandeveer, Amanda |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4645497 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46454972015-11-20 Systemic immunotherapy of superficial mouse bladder cancer with Avelumab (MSB0010718C), an anti-PD-L1 immune checkpoint inhibitor Vandeveer, Amanda Fallon, Jonathan Tighe, Robert Sabzevari, Helen Schlom, Jeffrey Greiner, John J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645497/ http://dx.doi.org/10.1186/2051-1426-3-S2-P70 Text en Copyright © 2015 Vandeveer et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Vandeveer, Amanda Fallon, Jonathan Tighe, Robert Sabzevari, Helen Schlom, Jeffrey Greiner, John Systemic immunotherapy of superficial mouse bladder cancer with Avelumab (MSB0010718C), an anti-PD-L1 immune checkpoint inhibitor |
| title | Systemic immunotherapy of superficial mouse bladder cancer with Avelumab (MSB0010718C), an anti-PD-L1 immune checkpoint inhibitor |
| title_full | Systemic immunotherapy of superficial mouse bladder cancer with Avelumab (MSB0010718C), an anti-PD-L1 immune checkpoint inhibitor |
| title_fullStr | Systemic immunotherapy of superficial mouse bladder cancer with Avelumab (MSB0010718C), an anti-PD-L1 immune checkpoint inhibitor |
| title_full_unstemmed | Systemic immunotherapy of superficial mouse bladder cancer with Avelumab (MSB0010718C), an anti-PD-L1 immune checkpoint inhibitor |
| title_short | Systemic immunotherapy of superficial mouse bladder cancer with Avelumab (MSB0010718C), an anti-PD-L1 immune checkpoint inhibitor |
| title_sort | systemic immunotherapy of superficial mouse bladder cancer with avelumab (msb0010718c), an anti-pd-l1 immune checkpoint inhibitor |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645497/ http://dx.doi.org/10.1186/2051-1426-3-S2-P70 |
| work_keys_str_mv | AT vandeveeramanda systemicimmunotherapyofsuperficialmousebladdercancerwithavelumabmsb0010718canantipdl1immunecheckpointinhibitor AT fallonjonathan systemicimmunotherapyofsuperficialmousebladdercancerwithavelumabmsb0010718canantipdl1immunecheckpointinhibitor AT tigherobert systemicimmunotherapyofsuperficialmousebladdercancerwithavelumabmsb0010718canantipdl1immunecheckpointinhibitor AT sabzevarihelen systemicimmunotherapyofsuperficialmousebladdercancerwithavelumabmsb0010718canantipdl1immunecheckpointinhibitor AT schlomjeffrey systemicimmunotherapyofsuperficialmousebladdercancerwithavelumabmsb0010718canantipdl1immunecheckpointinhibitor AT greinerjohn systemicimmunotherapyofsuperficialmousebladdercancerwithavelumabmsb0010718canantipdl1immunecheckpointinhibitor |